Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I ain't ever love nohoe, but picked NOHO lotto pick at .0003. Saw all the 100 share down ticks on afpw, prpm, fffc, and now NOHO
Will it continue, Rumors of MJ Rumors
I'm in at .0035, nice web interview 2 hours before the close, hopefully people get a chance to digest the hemp/drink news, Obama signs the bill and it runnnnnnsss
Heres to Hopin for a gap and runnnnn
FITX .0834 PRINTING NHOD!!!!!
FITX Market Makers putting in a bid at .0701
Fidelity ATP is a little screwy, can anyone confirm?
FITX- PHOT shareholder vote tomorrow
Tim Sykes tweeted to short cbis phot hemp mjna about 80 min ago
buy the dip :)
Fitx holding strong intraday above support, now testing .07, I picked up .065, hope it dips to .06 or lower to pick up more maybe tmrw for sell off fridays.
Alan Brochstein had a 3.5 hour convo with the CEO and is supposed to talk about them on Monday.
http://www.freep.com/article/20140206/BUSINESS06/302060025/creative-edge-medicinal-marijuana
Fitx holding strong intraday above support, now testing .07, I picked up .065, hope it dips to .06 or lower to pick up more maybe tmrw for sell off fridays.
Alan Brochstein had a 3.5 hour convo with the CEO and is supposed to talk about them on Monday.
http://www.freep.com/article/20140206/BUSINESS06/302060025/creative-edge-medicinal-marijuana
Tim Sykes tweeted to short cbis phot hemp mjna 1h ago
Picked up NECA .0016's on your alert too!
Enough liquidity for me :)
Looking for your .36 bounce call again :) that was snappy!
JALA, had turd for 8 months, now up!
Whats up with JALA today?
Same founder as skinny cow I believe.
They sent out flyers 10 months ago and the stock dropped waaay down, now looking alive what gives?
You think it will pop tomorrow now that NH legalized? (if the Gov doesn't veto)
getting into position before the close?
NH Legalizes MArijuana! Will it be VETO'ed?
GWPH 1AM NEWS LatanAmerica gets Sativex
I was waiting to buy a mid 40's dip but that may never come. May be the establishment MMJ Play.
Also ending today is their 30-Day Option to Buy Up to Additional 366,165 ADSs at Offering Price
Which according to last week:
LONDON (Alliance News) - GW Pharmaceuticals PLC Thursday said it has priced a follow-on offering of its American Depositary Shares on Nasdaq at USD36.00 an ADS, raising gross proceeds of USD87.9 million, or GBP53.4 million, before costs to help it develop a potential childhood epilepsy treatment.
AND Today's 1:00am news:
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America
The intended indication of Sativex® is the treatment of spasticity due to multiple sclerosis
Sativex® a companion drug to Dysport® in neurology
LONDON & PARIS--(BUSINESS WIRE)--Regulatory News:
Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announce that they have entered into an exclusive agreement for Ipsen to promote and distribute Sativex®1, a sublingual cannabis extract spray intended for the treatment of spasticity due to multiple sclerosis (MS) in Latin America (excluding Mexico and the Islands of the Caribbean). GW will be responsible for commercial product supply to Ipsen.
Sativex® is already approved in 24 countries (principally in Europe) as a treatment of spasticity due to multiple sclerosis. GW Pharmaceuticals and Ipsen aim to start regulatory filings in selected countries in Latin America during 2014 for the MS spasticity indication. The rights granted to Ipsen cover spasticity due to MS and also cover the future potential cancer pain indication. Financial terms include an upfront payment to GW Pharmaceuticals, regulatory and commercial milestone payments, and a long term supply price.
Justin Gover, Chief Executive Officer of GW, stated: “We are pleased to have expanded our commercial distribution agreements for Sativex® to include Latin America. Ipsen is an ideal partner with both a strong presence in the region as well as international expertise in the two therapeutic areas of neurology and oncology. We look forward to working with Ipsen to achieve successful approvals and launches of Sativex® across Latin America.”
Christophe Jean, Executive Vice-President, Strategy and Business Development, Ipsen stated: “Ipsen is delighted to enter into partnership with GW for Latin America, as Sativex® is a good complement to our neurology franchise portfolio in this region. Sativex® will bring added value to patients with spasticity due to multiple sclerosis. Furthermore, this partnership is fully aligned with our neurology franchise strategy focused on helping patients suffering from debilitating neurologic diseases, in particular spasticity.”
About Ipsen in Latin America
Ipsen has a direct presence in Brazil and Mexico and presence via various partners in other countries such as Colombia, Argentina, Venezuela, Chile and Peru. In Brazil, in the therapeutic area of neurology, Ipsen has consolidated its leadership position with Dysport® in the public market and grown its market share in the private segment.
About Sativex®
Sativex® is an endocannabinoid modulator made of two actives - THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). The product was developed, and is manufactured by GW. Sativex® contains active ingredients known as ‘cannabinoids’ which are extracted from the plant Cannabis Sativa grown and processed under strictly controlled conditions. As part of the human endocannabinoid system (ECS), cannabinoid receptors, CB1 and CB2 receptors are found predominantly at nerve terminals where they have a role in retrograde regulation of synaptic function. THC acts as a partial agonist at both CB1 and CB2 receptors, mimicking the effects of the endocannabinoids, which may modulate the effects of neurotransmitters (e.g. reduce effects of excitatory neurotransmitters such as glutamate).
Sativex® is indicated as an add-on treatment for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity-related symptoms during an initial trial of therapyi.
Sativex® is already approved in 24 countries (principally in Europe) as a treatment of spasticity due to multiple sclerosis (MS). Sativex® is also currently in a global Phase III program for the treatment of cancer pain.
Sativex® is already licensed to Otsuka Pharmaceutical Co., Ltd in the United States; to Almirall S.A. in Europe (excluding the UK) and Mexico; to Bayer in the UK and Canada; to Novartis in Australasia, Asia (excluding China and Japan), the Middle East (excluding Israel) and Africa; and to Neopharm in Israel.
About spasticity
Spasticity is a symptom defined as loss of mobility, painful spasms, stiffness and / or weakness of muscles, occurring in over 80% of MS sufferers in the course of the diseaseii. Spasticity can affect many aspects of the daily lives of patients with MS and is one of the main factors contributing to their distress and disabilityiii.
About GW Pharmaceuticals plc
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis. Sativex® is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. GW has established a world leading position in the development of plant-derived cannabinoid therapeutics and has a deep pipeline of additional clinical-stage cannabinoid product candidates targeting epilepsy (including an orphan pediatric epilepsy program), Type 2 diabetes, ulcerative colitis, glioma and schizophrenia. For further information, please visit www.gwpharm.com.
France Legalizes Marijuana-Based Drug To Treat Multiple Sclerosis
GWPH
http://www.huffingtonpost.com/2014/01/10/france-marijuana-based-drug-legalizes-multiple-sclerosis_n_4575780.html
PARIS (AP) — The French drug safety agency has approved commercial sales of a medicine derived from cannabis for the first time in France.
France's Health Ministry said in a statement Wednesday that sales of Sativex, produced by Britain's GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.
Sativex contains marijuana's two best known components — delta 9-THC and cannabidiol. The company's website says the medicine has already been launched in 11 countries and approved in more than a dozen others.
A number of countries have been easing curbs on the sale of cannabis-based products for medical use in recent years, and the U.S. state of Colorado allowed the nation's first legal recreational marijuana shops to open starting this year.
Awareness... :)
Devil Vs. Angel. Tough day for some, hopefully this cheers you up :)
GWPH up 23% looking like a good close above $47
EDXC says they will be tracking MJ for FITX
ICBU also getting in the weed game
CAVE CREEK, AZ -- (Marketwired) -- 01/09/14 -- Endexx Corporation(EDXC) to track and support through its M3 technology services up to 1.3 million pounds of Medical Marijuana annually for CEN Biotech, a division of Creative Edge Nutrition, Inc.(FITX). Health Canada enacted in December 2013 new regulations for the production and distribution of medical marijuana for the Canadian market under the "Marihuana for Medical Purposes Regulations" (MMPR), setting the rules for licensed commercial producers to grow, process and distribute marijuana products directly to marijuana patients and medical providers.
MMRP outlines tracking, recording and reporting requirements, in relation to transactions, client registration, security, production and inventory that licensed producers need to meet for compliance.
M3Hub Seed to Sale Tracking platform is ready to enter the Canadian medical Marijuana market through a contractual agreement entered between Endexx(EDXC) and CEN Biotech, a division of Creative Edge Nutrition(FITX) last November. CEN Biotech is expected to receive license to grow, and be able to export, up to 1.3M lbs. of marijuana products annually on a ten acre facility in Canada as of April 1, 2014.
Bill Chaaban, President & CEO of CEN Biotech, stated, "After canvassing the market of seed to sale software, we determined that the M3Hub Seed to Sale Tracking platform meets and exceeds the requirements as demanded by our facility and the governing regulatory authorities. These conclusions were made after carefully reviewing the screen shots and live demo of the software."
The M3Hub Seed to Sale Tracking platform meets and exceeds Health Canada's compliance thresholds:
M3Hub creates a web of traceable connections between all the critical touch points in the supply chain processes, tracking all activity from the origin of the seed to germination, cloning, nutrients, pesticide, fungicide, soil management, space conditioning, plant rotation, bud tending, "scrogging," harvesting, drying, processing, packaging, shipping, receiving, and sale to the end user/patient.
M3Hub also integrates security monitoring, personnel ID verification, RFID and barcode technology. The features provide a level of compliance that exceeds government level requirements. The touch points are varied and complex and the M3Hub platform offers the quickest path for licensed producers to efficiency and compliance and gives them the tools to optimize quality control, yield, growth cycles, strain management, processing, packaging and client management.
The M3Hub supply chain management system is integrated seamlessly between growers, processors and retailers. As applied to the Seed to Sale cycle, M3Hub has been shown to increase overall process efficiencies and productivity by up to 40% through accelerated crop cycles, reduced labor costs, improved product quality, inventory control, process management, improved customer experience and regulatory compliance.
M3Hub system components have been utilized in the trucking and shipping industries, agriculture grow operations, pharmaceuticals, CRM and POS applications for the past 10 years. The systems have been customized to uniquely provide the controls necessary to manage all medical marijuana processes and features down to their smallest components and derivatives.
A variable set of applications provides a complete set of services for each type of operation along the supply chain and each can be customized to the specific needs of growers, processors and vendors. These applications include:
User Account Management
Business Definition
Inventory Management
Sales Management
Shipping/Transfer Tracking
Reporting
Data Tracking
Customized Automation
Regional Data Management
Point of Sale or Final Transaction Assistance
M3Hub plans to expand its collaboration efforts with producers in new legalized markets both in the US and internationally and develop Seed to Sale management solutions that are market specific, adaptable for international trade, scalable, secure and compliant and will ultimately provide standardization for the Cannabusiness Industry.
About Endexx(EDXC) :
www.endexx.com, www.gsgsolar.com, www.m3hub.com, www.autospense.com, www.THCFinder.com
Endexx Corporation (EDXC) is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's(EDXC) team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx(EDXC) management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation (EDXC) is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
Contact Endexx(EDXC) via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Contact:
Todd Davis
endexx@endexx.com
Wowza, that stock has some of the best minds working in MMJ , but I believe they said a few months ago they would not be able to continue operations without further financing.
Wish I didn't sell 2 days ago
*Crying Baby Face"
GWPH The establishment MMJ Candidate with larger than normal volume today looks like its starting to move now at 42.75
I own very little at $40, remember eyeing it at 9 bucks.
They market a oral spray called Sativex, its been in use in the UK and the US is now accepting its use.
I know they are supposed to be sad but, the baby faces have been CRACKING me up lately! :)
A TRTC rep was on bloomburg last night:
Just saw this forbes article mentioning FITX.
http://www.forbes.com/sites/karstenstrauss/2013/12/30/big-marijuana-is-it-the-future/
Stinky pinky or smart money move?
Nice sell price. I got out at $2.39 this morning from $1.11.
Looking for re-entry, what pps do you think? Could make some money on tuesday if timed correctly
You mean David Gwyther?
"He has been a lobbyist representing both political and business interests in Oregon. He worked as a stock broker at Wedbush, Paulson Investments, and National Securities from 1980 to 1989. From 1990-2004 David worked at Blackwell Donaldson as an Investment Banker."
And dont forget about the new appointent Mr. Sean Loomer, who started one of the first prepaid phone card companies which he got into thousands of retail storefronts. Annnnnd guess who is in charge of getting the Green Machine into all the dispensaries?
This guy is legit, he owns a health food company and as you can tell from his videos, he is a articulate, honest guy, who cares a lot about health.
This company is full of upstanding members that I actually trust, just look into them for yourselves!
ERBB for the long money baby!!!
Altitude Organix Network customers will receive a membership card and embedded in the card will be a RFID tag containing encrypted information about the persons membership status enabling identification safe guards inventory control such as if their is a legal limit to how much mj can be purchased within a single time period then the inventory network can maintain quantities bought in relation to whatever time frame hence enabling regulation, one reason why the system has received a lot of support. In comparison to "the other guys" system which is not designed for the despinsory of recreational items it is designed to require Rx's and is marketed as an automated dispensing unit for Rx drugs.
Chuga.....Chuga.....Chuga.....
CHOOO!!!!! CHOOOO!!!!!
$$ERBB$$
Yee of little faith, .0028 and buyers are coming in
Low volume consolidation is looking beautiful, can't wait for the BOOM!
$$IDVC$$
The People of Tranzbyte (ERBB) -COO Update-
DAVID G. GWYTHER, PRESIDENT - TRANZBYTE CORP.
Mr. Gwyther will assume the responsibility for the corporation's business development, corporate, and investor relations so the current president, Brian Cook can focus on the growth of the Altitude Organix business unit.
David comes to us from Portland, Oregon. David has been a lobbyist representing both political and business interests in Oregon. He worked as a stock broker at Wedbush, Paulson Investments, and National Securities from 1980 to 1989. From 1990-2004 David worked at Blackwell Donaldson as an Investment Banker. David has also garnered extensive experience as a successful entrepreneur in multiple fields including publishing, consulting, lobbying, and magazine distribution. David’s wealth of resources, knowledge, and connections will lend credibility and credence to the company’s effort to commercialize its technology assets while also building the medical marijuana division of the company.
SEAN LOOMER, CHIEF OPERATING OFFICER - TRANZBYTE CORP.
Mr. Loomer’s career serves as a benchmark for successful U.S. professionals. At MCI Telecommunications, he was the #1 Regional Manager in the country where he developed small business strategies that were implemented throughout the U.S. Mr. Loomer went on to found the first privately held prepaid phone card company in Arizona in 1993, creating thousands of outlets with wholesale and retail distributors. After selling that company in 1997 he went on to found a prepaid banking company in 2002 and operated in that space for several years. In 2006, he co-founded ONE BODE which he partnered with 2-time NBA MVP, Steve Nash.
BRIAN J. COOK, MANAGING DIRECTOR - ALTITUDE ORGANICS CORPORATION
Brian Cook is the founder and managing director of Altitude Organic Corporation. Prior to starting Altitude Organic in 2009, Brian worked as a partner in a boutique investment firm called The Regency Group for 9 years. He specialized in raising seed capital for emerging companies while providing business development services to start-ups across a wide array of industries. Through real world, corporate mergers and acquisitions, Brian gained the skills and knowledge to lead start-up companies to major growth and success. Brian also used to own–and successfully turned around to profitability–one of the largest bars in Northern Colorado, Washington’s Sports Bar & Grill. Brian Cook holds a bachelor of applied human sciences from Colorado State University. Brian currently sits as a founding Board of Director for The National Cannabis Industry Association, TheCannabisIndustry.org. The trade group is only national trade association for the industry located in Washington.
COLLEEN MANLEY, DIRECTOR - TRANZBYTE COPORATION
Colleen Manley is a partner of one of Arizona's oldest family law practices. She has been a member of the Arizona State Bar since 1985. In 1986, she was admitted to US Court of Appeals for the Ninth Circuit. As an attorney, Ms. Manley has earned the coveted "AV" rating, and her firm, Manley Law has been awarded "pre-eminent" status. Ms. Manley is also related to Tom Forcade, the founder of High Times magazine, the most popular periodical on the subject of marijuana in the US. She also serves on the Board of Trans High Corporation, the owner of High Times, and is actively involved in many start-up ventures, both here in the US and around the world.
JOHN G. STOESSINGER - BOARD OF ADVISORS
Dr. Stoessinger is an internationally recognized political analyst and the prize-winning of ten books on international politics. He holds a PH.d from Harvard University and has taught at Harvard, MIT, Columbia, and Princeton. From 1967 to 1974, Dr. Stoessinger served as the acting Director of Political Affairs for the United Nations. He is a member of the Council on Foreign Relations and lectures extensively throughout the world. He is included in the Marquiss Who's Who in America and Who's Who in the World.
WILLIAM B. HASELTINE - COPORATE COUNSEL
Mr. Haseltine has over 20 years of experience in corporate and securities law. He had spent more than 9 years working for the US Securties and Exchange Commission where he served as special counsel working in the Office of Disclosure Policy, the Office of Chief Counsel, and the Office of Disclosure Operations. He is an expert in small business, and has spent many years assisting companies in their formation, capitalization, and regulatory compliance. Mr. Haseltine practices in the both the US and internationally, and has provided his services to several countries seeking advice defining, creating, and implementing quality securities laws and regulations and has access to contacts and expertise throughout the world.
Wow big hands getting in.
1.29 Million on .091. aw snap
So happy these shares are getting into strong hands.
Looks like we got the rocket fuel we need. Vending Machine MADNESS MUAHaHaHAhahaha!!!
The Cell phone APP to go with the vending machine is such a huge thing the average person doesn't understand the futre is wireless access.
This company is making correct step at the exact correct time. The main player took a huge dive today, guess where the money went!!!!!!!!! ERBB!!!!!
And its not even 4/20
Bouncy...Bouncy...Bouncyy :)
It's bouncing off 2 & 3 days ago's low price. This is a time to buy not sell, but as always...we'll see.
IDVC BUYERS BACK IN CONTROL HAHAHAH!
LOADING ZONE!!!!!!!!!!
I watched this all morning, tried to pull the trigger @ .0027 now in at .0036.
Usually I don't ever chase but its hards to deny 42 million in rev.
IDVC RESPECT!
I told my mama to buy at .0051, RUUUUUSSPECT
That b better have traded on my text, ruuusspecttt.
Dolla' Dolla' Bills Y'all.
RESPECT.
IDVC
IDVC bouncing nicely off SMA50 up up up. Looks so nice on the 1 day 1 min chart; Resembles a stone skipping over a lake.
Oh you don't think we mirror MJNA?
What do these charts look like?
http://www.flickr.com/photos/69589065@N04/8534364485/
http://www.flickr.com/photos/69589065@N04/8535472986/
http://www.flickr.com/photos/69589065@N04/8535472982/
ERBB may be primed for a breakout.
We hit the 50MA, we had a press release which people should read about tmrw and Eric Holder said he is talking/working with the states on the MJ issues today during the meeting. The interviewing senator is personally behind letting the states choose for them selves, and not wasting anymore money, (like holders private jet trips) perhaps he will act as a barometer for the rest of congress.
If you guys are wondering why our price is falling, it's because we mirror MJNA perfectly.